| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |